Accolade: Staying Bullish On Favorable Developments
Accolade(ACCD) Seeking Alpha·2024-04-05 10:34ipopba Elevator Pitch Accolade, Inc. (NASDAQ:ACCD) shares are rated as a Buy. Business data provider GlobalData refers to ACCD as a "personalized healthcare advocacy company" that "reduces healthcare costs for employers and improves health and benefits for employees." I reviewed Accolade's financial performance for the third quarter of fiscal 2024 (September 1, 2023 to November 30, 2023) in my previous update written on January 10 this year. With the latest article, I analyze ACCD's recent corporate develop ...